Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Driven by the downstream end-users, the market of Peptide Hormones witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Peptide Hormones market is offered. The research provides insights for the global Peptide Hormones market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Peptide Hormones industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Peptide Hormones Market Segmentations:
By Players:
Mylan
Novo nordisk
Alcon
Eli lilly
Alexion pharmaceuticals
Nabi biopharmaceuticals (now biota pharmaceuticals)
Protein sciences corporation
Janssen-cilag
Bristol-myers squibb
Btg international
Dendreon
Fresenius kabi
Abbott laboratories
Cangene
Ferring pharmaceuticals
Kedrion biopharmaceuticals
Pfizer
Kamada
Hoffman-la-roche
Sandoz
Rare disease therapeutics
Boehringer ingelheim
Hospira
Revo biologics
Eisai
Merck
Glaxosmithkline
Novartis
Octapharma pharmazeutika produktionsges.m.b.h
Omrix biopharmaceuticals
Affymax
Biogen
Biotest pharmaceuticals
Johnson & johnson
Csl
Allergan
Sanofi
Lundbeck
Medimmune
Grifols biologicals
By Types:
Follicle-stimulating Hormone and Luteinizing Hormone
Adrenocorticotropic Hormone
Growth Hormones
Erythropoietin
Insulin
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Reasons to Purchase the Peptide Hormones Market Report
-
Vertical Market Divisions by Type and End-Users
-
The Most Promising Regions in the Forecast Period
-
Competitive Landscape
-
Key Players’ Strategies and Their Product Offerings
-
Peptide Hormones Market Current Trends/Restraints/Challenges/Opportunities
-
Potential and Niche Market / Regions with Promising Growth
-
Objective Analysis Towards Market Performance
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide Hormones Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Peptide Hormones Market Share by Types
1.3.2 Global Peptide Hormones Market Size and Growth Rate of Follicle-stimulating Hormone and Luteinizing Hormone from 2013 to 2025
1.3.3 Global Peptide Hormones Market Size and Growth Rate of Adrenocorticotropic Hormone from 2013 to 2025
1.3.4 Global Peptide Hormones Market Size and Growth Rate of Growth Hormones from 2013 to 2025
1.3.5 Global Peptide Hormones Market Size and Growth Rate of Erythropoietin from 2013 to 2025
1.3.6 Global Peptide Hormones Market Size and Growth Rate of Insulin from 2013 to 2025
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Peptide Hormones Market Share by End-Users
1.4.2 Global Peptide Hormones Market Size and Growth Rate of End-User 1 from 2013 to 2025
1.4.3 Global Peptide Hormones Market Size and Growth Rate of End-User 2 from 2013 to 2025
1.4.4 Global Peptide Hormones Market Size and Growth Rate of End-User 3 from 2013 to 2025
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.1.1 United States Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.1.2 Canada Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.1.3 Mexico Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2 Europe Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.1 Germany Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.2 UK Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.3 France Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.4 Italy Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.5 Nordic Countries Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.6 Spain Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.7 BelgiumPeptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.8 Poland Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.9 Russia Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.2.10 Turkey Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3 Asia-Pacific Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.1 China Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.2 Japan Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.3 Australia and New Zealand Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.4 India Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.5 ASEAN Countries Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.3.6 South Korea Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4 Latin America, Middle East & Africa Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.1 GCC Countries Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.2 Brazil Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.3 Nigeria Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.4 South Africa Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
1.5.4.5 Argentina Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Peptide Hormones Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptide Hormones by Major Types
3.4.1 Market Size and Growth Rate of Follicle-stimulating Hormone and Luteinizing Hormone
3.4.2 Market Size and Growth Rate of Adrenocorticotropic Hormone
3.4.3 Market Size and Growth Rate of Growth Hormones
3.4.4 Market Size and Growth Rate of Erythropoietin
3.4.5 Market Size and Growth Rate of Insulin
4 Segmentation of Peptide Hormones Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptide Hormones by Major End-Users
4.4.1 Market Size and Growth Rate of Peptide Hormones for End-Users 1
4.4.2 Market Size and Growth Rate of Peptide Hormones for End-Users 2
4.4.3 Market Size and Growth Rate of Peptide Hormones for End-Users 3
5 Market Analysis by Major Regions
-
5.1 Global Peptide Hormones Production Analysis by Major Regions
-
5.2 Global Peptide Hormones Consumption Analysis by Major Regions
-
5.3 Global Peptide Hormones Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Peptide Hormones Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Peptide Hormones Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Peptide Hormones Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Peptide Hormones Production, Import, Consumption and Export Analysis
6 Product Commodity of Peptide Hormones Market in Major Countries
-
6.1 Top 5 Export Countries in Peptide Hormones market from 2013 to 2018
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Peptide Hormones market from 2013 to 2018
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Peptide Hormones market from 2013 to 2018
-
6.2 Top 5 Import Countries in Peptide Hormones market from 2013 to 2018
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Peptide Hormones market from 2013 to 2018
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Peptide Hormones market from 2013 to 2018
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Peptide Hormones Landscape Analysis
-
7.1 North America Peptide Hormones Landscape Analysis by Major Types
-
7.2 North America Peptide Hormones Landscape Analysis by Major End-Users
-
7.3 North America Peptide Hormones Landscape Analysis by Major Countries
-
7.3.1 United States Peptide Hormones Market Volume and Growth Rate
-
7.3.2 Canada Peptide Hormones Market Volume and Growth Rate
-
7.3.3 Mexico Peptide Hormones Market Volume and Growth Rate
8 Europe Peptide Hormones Landscape Analysis
-
8.1 Europe Peptide Hormones Landscape Analysis by Major Types
-
8.2 Europe Peptide Hormones Landscape Analysis by Major End-Users
-
8.3 Europe Peptide Hormones Landscape Analysis by Major Countries
-
8.3.1 Germany Peptide Hormones Market Volume and Growth Rate
-
8.3.2 UK Peptide Hormones Market Volume and Growth Rate
-
8.3.3 France Peptide Hormones Market Volume and Growth Rate
-
8.3.4 Italy Peptide Hormones Market Volume and Growth Rate
-
8.3.5 Nordic Countries Peptide Hormones Market Volume and Growth Rate
-
8.3.6 Spain Peptide Hormones Market Volume and Growth Rate
-
8.3.7 Belgium Peptide Hormones Market Volume and Growth Rate
-
8.3.8 Poland Peptide Hormones Market Volume and Growth Rate
-
8.3.9 Russia Peptide Hormones Market Volume and Growth Rate
-
8.3.10 Turkey Peptide Hormones Market Volume and Growth Rate
9 Asia Pacific Peptide Hormones Landscape Analysis
-
9.1 Asia Pacific Peptide Hormones Landscape Analysis by Major Types
-
9.2 Asia Pacific Peptide Hormones Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Peptide Hormones Landscape Analysis by Major Countries
-
9.3.1 China Peptide Hormones Market Volume and Growth Rate
-
9.3.2 Japan Peptide Hormones Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Peptide Hormones Market Volume and Growth Rate
-
9.3.4 India Peptide Hormones Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Peptide Hormones Market Volume and Growth Rate
-
9.3.6 South Korea Peptide Hormones Market Volume and Growth Rate
10 Latin America, Middle East & Africa Peptide Hormones Landscape Analysis
-
10.1 Latin America, Middle East & Africa Peptide Hormones Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Peptide Hormones Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Peptide Hormones Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Peptide Hormones Market Volume and Growth Rate
-
10.3.2 Brazil Peptide Hormones Market Volume and Growth Rate
-
10.3.3 Nigeria Peptide Hormones Market Volume and Growth Rate
-
10.3.4 South Africa Peptide Hormones Market Volume and Growth Rate
-
10.3.5 Argentina Peptide Hormones Market Volume and Growth Rate
11 Major Players Profile
11.1 Mylan
11.1.1 Mylan Company Profile and Development Status
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Novo nordisk
11.2.1 Novo nordisk Company Profile and Development Status
11.2.2 Market Performance
11.2.3 Product and Service Introduction
11.3 Alcon
11.3.1 Alcon Company Profile and Development Status
11.3.2 Market Performance
11.3.3 Product and Service Introduction
11.4 Eli lilly
11.4.1 Eli lilly Company Profile and Development Status
11.4.2 Market Performance
11.4.3 Product and Service Introduction
11.5 Alexion pharmaceuticals
11.5.1 Alexion pharmaceuticals Company Profile and Development Status
11.5.2 Market Performance
11.5.3 Product and Service Introduction
11.6 Nabi biopharmaceuticals (now biota pharmaceuticals)
11.6.1 Nabi biopharmaceuticals (now biota pharmaceuticals) Company Profile and Development Status
11.6.2 Market Performance
11.6.3 Product and Service Introduction
11.7 Protein sciences corporation
11.7.1 Protein sciences corporation Company Profile and Development Status
11.7.2 Market Performance
11.7.3 Product and Service Introduction
11.8 Janssen-cilag
11.8.1 Janssen-cilag Company Profile and Development Status
11.8.2 Market Performance
11.8.3 Product and Service Introduction
11.9 Bristol-myers squibb
11.9.1 Bristol-myers squibb Company Profile and Development Status
11.9.2 Market Performance
11.9.3 Product and Service Introduction
11.10 Btg international
11.10.1 Btg international Company Profile and Development Status
11.10.2 Market Performance
11.10.3 Product and Service Introduction
11.11 Dendreon
11.11.1 Dendreon Company Profile and Development Status
11.11.2 Market Performance
11.11.3 Product and Service Introduction
11.12 Fresenius kabi
11.12.1 Fresenius kabi Company Profile and Development Status
11.12.2 Market Performance
11.12.3 Product and Service Introduction
11.13 Abbott laboratories
11.13.1 Abbott laboratories Company Profile and Development Status
11.13.2 Market Performance
11.13.3 Product and Service Introduction
11.14 Cangene
11.14.1 Cangene Company Profile and Development Status
11.14.2 Market Performance
11.14.3 Product and Service Introduction
11.15 Ferring pharmaceuticals
11.15.1 Ferring pharmaceuticals Company Profile and Development Status
11.15.2 Market Performance
11.15.3 Product and Service Introduction
11.16 Kedrion biopharmaceuticals
11.16.1 Kedrion biopharmaceuticals Company Profile and Development Status
11.16.2 Market Performance
11.16.3 Product and Service Introduction
11.17 Pfizer
11.17.1 Pfizer Company Profile and Development Status
11.17.2 Market Performance
11.17.3 Product and Service Introduction
11.18 Kamada
11.18.1 Kamada Company Profile and Development Status
11.18.2 Market Performance
11.18.3 Product and Service Introduction
11.19 Hoffman-la-roche
11.19.1 Hoffman-la-roche Company Profile and Development Status
11.19.2 Market Performance
11.19.3 Product and Service Introduction
11.20 Sandoz
11.20.1 Sandoz Company Profile and Development Status
11.20.2 Market Performance
11.20.3 Product and Service Introduction
11.21 Rare disease therapeutics
11.21.1 Rare disease therapeutics Company Profile and Development Status
11.21.2 Market Performance
11.21.3 Product and Service Introduction
11.22 Boehringer ingelheim
11.22.1 Boehringer ingelheim Company Profile and Development Status
11.22.2 Market Performance
11.22.3 Product and Service Introduction
11.23 Hospira
11.23.1 Hospira Company Profile and Development Status
11.23.2 Market Performance
11.23.3 Product and Service Introduction
11.24 Revo biologics
11.24.1 Revo biologics Company Profile and Development Status
11.24.2 Market Performance
11.24.3 Product and Service Introduction
11.25 Eisai
11.25.1 Eisai Company Profile and Development Status
11.25.2 Market Performance
11.25.3 Product and Service Introduction
11.26 Merck
11.26.1 Merck Company Profile and Development Status
11.26.2 Market Performance
11.26.3 Product and Service Introduction
11.27 Glaxosmithkline
11.27.1 Glaxosmithkline Company Profile and Development Status
11.27.2 Market Performance
11.27.3 Product and Service Introduction
11.28 Novartis
11.28.1 Novartis Company Profile and Development Status
11.28.2 Market Performance
11.28.3 Product and Service Introduction
11.29 Octapharma pharmazeutika produktionsges.m.b.h
11.29.1 Octapharma pharmazeutika produktionsges.m.b.h Company Profile and Development Status
11.29.2 Market Performance
11.29.3 Product and Service Introduction
11.30 Omrix biopharmaceuticals
11.30.1 Omrix biopharmaceuticals Company Profile and Development Status
11.30.2 Market Performance
11.30.3 Product and Service Introduction
11.31 Affymax
11.31.1 Affymax Company Profile and Development Status
11.31.2 Market Performance
11.31.3 Product and Service Introduction
11.32 Biogen
11.32.1 Biogen Company Profile and Development Status
11.32.2 Market Performance
11.32.3 Product and Service Introduction
11.33 Biotest pharmaceuticals
11.33.1 Biotest pharmaceuticals Company Profile and Development Status
11.33.2 Market Performance
11.33.3 Product and Service Introduction
11.34 Johnson & johnson
11.34.1 Johnson & johnson Company Profile and Development Status
11.34.2 Market Performance
11.34.3 Product and Service Introduction
11.35 Csl
11.35.1 Csl Company Profile and Development Status
11.35.2 Market Performance
11.35.3 Product and Service Introduction
11.36 Allergan
11.36.1 Allergan Company Profile and Development Status
11.36.2 Market Performance
11.36.3 Product and Service Introduction
11.37 Sanofi
11.37.1 Sanofi Company Profile and Development Status
11.37.2 Market Performance
11.37.3 Product and Service Introduction
11.38 Lundbeck
11.38.1 Lundbeck Company Profile and Development Status
11.38.2 Market Performance
11.38.3 Product and Service Introduction
11.39 Medimmune
11.39.1 Medimmune Company Profile and Development Status
11.39.2 Market Performance
11.39.3 Product and Service Introduction
11.40 Grifols biologicals
11.40.1 Grifols biologicals Company Profile and Development Status
11.40.2 Market Performance
11.40.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 80 Figures and 147 Tables)
-
Figure Product Picture
Figure Global Peptide Hormones Market Size and Growth Rate of Follicle-stimulating Hormone and Luteinizing Hormone from 2013 to 2025
Figure Global Peptide Hormones Market Size and Growth Rate of Adrenocorticotropic Hormone from 2013 to 2025
Figure Global Peptide Hormones Market Size and Growth Rate of Growth Hormones from 2013 to 2025
Figure Global Peptide Hormones Market Size and Growth Rate of Erythropoietin from 2013 to 2025
Figure Global Peptide Hormones Market Size and Growth Rate of Insulin from 2013 to 2025
-
Figure Market Share by Type in 2013
-
Figure Market Share by Type in 2017
-
Figure Market Share by Type in 2025
Figure Global Peptide Hormones Market Size and Growth Rate of End-User 1 from 2013 to 2025
Figure Global Peptide Hormones Market Size and Growth Rate of End-User 2 from 2013 to 2025
Figure Global Peptide Hormones Market Size and Growth Rate of End-User 3 from 2013 to 2025
-
Figure Market Share by End-User in 2013
-
Figure Market Share by End-User in 2017
-
Figure Market Share by End-User in 2025
-
Figure North America Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure United States Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Canada Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Mexico Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Europe Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Germany Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure UK Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure France Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Italy Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Nordic Countries Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Spain Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Belgium Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Poland Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Russia Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Turkey Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Asia-Pacific Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure China Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Japan Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Australia and New Zealand Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure India Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure ASEAN Countries Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure South Korea Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure GCC Countries Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Brazil Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Nigeria Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure South Africa Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Argentina Peptide Hormones Consumption Market Size and Growth Rate from 2013 to 2025
-
Figure Development Trends and Industry Dynamics of Peptide Hormones Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2017
-
Figure Market Share of TOP 5 Players in 2017
-
Figure Market Share of TOP 6 Players from 2013 to 2018
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Peptide Hormones
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptide Hormones by Different Types from 2013 to 2025
-
Table Consumption Share of Peptide Hormones by Different Types from 2013 to 2025
Figure Market Size and Growth Rate of Follicle-stimulating Hormone and Luteinizing Hormone
Figure Market Size and Growth Rate of Adrenocorticotropic Hormone
Figure Market Size and Growth Rate of Growth Hormones
Figure Market Size and Growth Rate of Erythropoietin
Figure Market Size and Growth Rate of Insulin
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Peptide Hormones by Different End-Users from 2013 to 2025
-
Table Consumption Share of Peptide Hormones by Different End-Users from 2013 to 2025
Figure Market Size and Growth Rate of End-User 1
Figure Market Size and Growth Rate of End-User 2
Figure Market Size and Growth Rate of End-User 3
-
Table Global Peptide Hormones Production by Major Regions
-
Table Global Peptide Hormones Production Share by Major Regions
-
Figure Global Peptide Hormones Production Share by Major Regions in 2013
-
Figure Global Peptide Hormones Production Share by Major Regions in 2018
-
Figure Global Peptide Hormones Production Share by Major Regions in 2025
-
Table Global Peptide Hormones Consumption by Major Regions
-
Table Global Peptide Hormones Consumption Share by Major Regions
-
Figure Global Peptide Hormones Consumption Share by Major Regions in 2013
-
Figure Global Peptide Hormones Consumption Share by Major Regions in 2018
-
Figure Global Peptide Hormones Consumption Share by Major Regions in 2025
-
Table North America Peptide Hormones Production, Import, Consumption and Export Analysis
-
Table Europe Peptide Hormones Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Peptide Hormones Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Peptide Hormones Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Peptide Hormones market from 2013 to 2018
-
Table Top 5 Export Countries' Export Volume Analysis in Peptide Hormones market from 2013 to 2018
-
Table Top 5 Import Countries' Import Value Analysis in Peptide Hormones market from 2013 to 2018
-
Table Top 5 Import Countries' Import Volume Analysis in Peptide Hormones market from 2013 to 2018
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Peptide Hormones Consumption by Types from 2013 to 2025
-
Table North America Peptide Hormones Consumption Share by Types from 2013 to 2025
-
Figure North America Peptide Hormones Consumption Share by Types in 2013
-
Figure North America Peptide Hormones Consumption Share by Types in 2018
-
Figure North America Peptide Hormones Consumption Share by Types in 2025
-
Table North America Peptide Hormones Consumption by End-Users from 2013 to 2025
-
Table North America Peptide Hormones Consumption Share by End-Users from 2013 to 2025
-
Figure North America Peptide Hormones Consumption Share by End-Users in 2013
-
Figure North America Peptide Hormones Consumption Share by End-Users in 2018
-
Figure North America Peptide Hormones Consumption Share by End-Users in 2025
-
Table North America Peptide Hormones Consumption by Major Countries from 2013 to 2025
-
Table North America Peptide Hormones Consumption Share by Major Countries from 2013 to 2025
-
Figure North America Peptide Hormones Consumption Share by Major Countries in 2013
-
Figure North America Peptide Hormones Consumption Share by Major Countries in 2018
-
Figure North America Peptide Hormones Consumption Share by Major Countries in 2025
-
Figure United States Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Canada Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Mexico Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Table Europe Peptide Hormones Consumption by Types from 2013 to 2025
-
Table Europe Peptide Hormones Consumption Share by Types from 2013 to 2025
-
Figure Europe Peptide Hormones Consumption Share by Types in 2013
-
Figure Europe Peptide Hormones Consumption Share by Types in 2018
-
Figure Europe Peptide Hormones Consumption Share by Types in 2025
-
Table Europe Peptide Hormones Consumption by End-Users from 2013 to 2025
-
Table Europe Peptide Hormones Consumption Share by End-Users from 2013 to 2025
-
Figure Europe Peptide Hormones Consumption Share by End-Users in 2013
-
Figure Europe Peptide Hormones Consumption Share by End-Users in 2018
-
Figure Europe Peptide Hormones Consumption Share by End-Users in 2025
-
Table Europe Peptide Hormones Consumption by Major Countries from 2013 to 2025
-
Table Europe Peptide Hormones Consumption Share by Major Countries from 2013 to 2025
-
Figure Europe Peptide Hormones Consumption Share by Major Countries in 2013
-
Figure Europe Peptide Hormones Consumption Share by Major Countries in 2018
-
Figure Europe Peptide Hormones Consumption Share by Major Countries in 2025
-
Figure Germany Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure UK Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure France Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Italy Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Nordic Countries Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Belgium Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Poland Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Russia Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Turkey Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Table Asia Pacific Peptide Hormones Consumption by Types from 2013 to 2025
-
Table Asia Pacific Peptide Hormones Consumption Share by Types from 2013 to 2025
-
Figure Asia Pacific Peptide Hormones Consumption Share by Types in 2013
-
Figure Asia Pacific Peptide Hormones Consumption Share by Types in 2018
-
Figure Asia Pacific Peptide Hormones Consumption Share by Types in 2025
-
Table Asia Pacific Peptide Hormones Consumption by End-Users from 2013 to 2025
-
Table Asia Pacific Peptide Hormones Consumption Share by End-Users from 2013 to 2025
-
Figure Asia Pacific Peptide Hormones Consumption Share by End-Users in 2013
-
Figure Asia Pacific Peptide Hormones Consumption Share by End-Users in 2018
-
Figure Asia Pacific Peptide Hormones Consumption Share by End-Users in 2025
-
Table Asia Pacific Peptide Hormones Consumption by Major Countries from 2013 to 2025
-
Table Asia Pacific Peptide Hormones Consumption Share by Major Countries from 2013 to 2025
-
Figure Asia Pacific Peptide Hormones Consumption Share by Major Countries in 2013
-
Figure Asia Pacific Peptide Hormones Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Peptide Hormones Consumption Share by Major Countries in 2025
-
Figure China Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Japan Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Australia and New ZealandPeptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure India Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure ASEAN Countries Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure South Korea Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Table Latin America, Middle East & Africa Peptide Hormones Consumption by Types from 2013 to 2025
-
Table Latin America, Middle East & Africa Peptide Hormones Consumption Share by Types from 2013 to 2025
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by Types in 2013
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by Types in 2025
-
Table Latin America, Middle East & Africa Peptide Hormones Consumption by End-Users from 2013 to 2025
-
Table Latin America, Middle East & Africa Peptide Hormones Consumption Share by End-Users from 2013 to 2025
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by End-Users in 2013
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by End-Users in 2025
-
Table Latin America, Middle East & Africa Peptide Hormones Consumption by Major Countries from 2013 to 2025
-
Table Latin America, Middle East & Africa Peptide Hormones Consumption Share by Major Countries from 2013 to 2025
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by Major Countries in 2013
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Peptide Hormones Consumption Share by Major Countries in 2025
-
Figure GCC Countries Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Brazil Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Nigeria Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure South Africa Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
-
Figure Argentina Peptide Hormones Market Volume and Growth Rate from 2013 to 2025
Table Company Profile and Development Status of Mylan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
Figure Sales and Growth Rate Analysis of Mylan
Figure Revenue and Market Share Analysis of Mylan
Table Product and Service Introduction of Mylan
Table Company Profile and Development Status of Novo nordisk
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo nordisk
Figure Sales and Growth Rate Analysis of Novo nordisk
Figure Revenue and Market Share Analysis of Novo nordisk
Table Product and Service Introduction of Novo nordisk
Table Company Profile and Development Status of Alcon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alcon
Figure Sales and Growth Rate Analysis of Alcon
Figure Revenue and Market Share Analysis of Alcon
Table Product and Service Introduction of Alcon
Table Company Profile and Development Status of Eli lilly
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli lilly
Figure Sales and Growth Rate Analysis of Eli lilly
Figure Revenue and Market Share Analysis of Eli lilly
Table Product and Service Introduction of Eli lilly
Table Company Profile and Development Status of Alexion pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alexion pharmaceuticals
Figure Sales and Growth Rate Analysis of Alexion pharmaceuticals
Figure Revenue and Market Share Analysis of Alexion pharmaceuticals
Table Product and Service Introduction of Alexion pharmaceuticals
Table Company Profile and Development Status of Nabi biopharmaceuticals (now biota pharmaceuticals)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nabi biopharmaceuticals (now biota pharmaceuticals)
Figure Sales and Growth Rate Analysis of Nabi biopharmaceuticals (now biota pharmaceuticals)
Figure Revenue and Market Share Analysis of Nabi biopharmaceuticals (now biota pharmaceuticals)
Table Product and Service Introduction of Nabi biopharmaceuticals (now biota pharmaceuticals)
Table Company Profile and Development Status of Protein sciences corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein sciences corporation
Figure Sales and Growth Rate Analysis of Protein sciences corporation
Figure Revenue and Market Share Analysis of Protein sciences corporation
Table Product and Service Introduction of Protein sciences corporation
Table Company Profile and Development Status of Janssen-cilag
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen-cilag
Figure Sales and Growth Rate Analysis of Janssen-cilag
Figure Revenue and Market Share Analysis of Janssen-cilag
Table Product and Service Introduction of Janssen-cilag
Table Company Profile and Development Status of Bristol-myers squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-myers squibb
Figure Sales and Growth Rate Analysis of Bristol-myers squibb
Figure Revenue and Market Share Analysis of Bristol-myers squibb
Table Product and Service Introduction of Bristol-myers squibb
Table Company Profile and Development Status of Btg international
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Btg international
Figure Sales and Growth Rate Analysis of Btg international
Figure Revenue and Market Share Analysis of Btg international
Table Product and Service Introduction of Btg international
Table Company Profile and Development Status of Dendreon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dendreon
Figure Sales and Growth Rate Analysis of Dendreon
Figure Revenue and Market Share Analysis of Dendreon
Table Product and Service Introduction of Dendreon
Table Company Profile and Development Status of Fresenius kabi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius kabi
Figure Sales and Growth Rate Analysis of Fresenius kabi
Figure Revenue and Market Share Analysis of Fresenius kabi
Table Product and Service Introduction of Fresenius kabi
Table Company Profile and Development Status of Abbott laboratories
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott laboratories
Figure Sales and Growth Rate Analysis of Abbott laboratories
Figure Revenue and Market Share Analysis of Abbott laboratories
Table Product and Service Introduction of Abbott laboratories
Table Company Profile and Development Status of Cangene
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cangene
Figure Sales and Growth Rate Analysis of Cangene
Figure Revenue and Market Share Analysis of Cangene
Table Product and Service Introduction of Cangene
Table Company Profile and Development Status of Ferring pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring pharmaceuticals
Figure Sales and Growth Rate Analysis of Ferring pharmaceuticals
Figure Revenue and Market Share Analysis of Ferring pharmaceuticals
Table Product and Service Introduction of Ferring pharmaceuticals
Table Company Profile and Development Status of Kedrion biopharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion biopharmaceuticals
Figure Sales and Growth Rate Analysis of Kedrion biopharmaceuticals
Figure Revenue and Market Share Analysis of Kedrion biopharmaceuticals
Table Product and Service Introduction of Kedrion biopharmaceuticals
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Kamada
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada
Figure Sales and Growth Rate Analysis of Kamada
Figure Revenue and Market Share Analysis of Kamada
Table Product and Service Introduction of Kamada
Table Company Profile and Development Status of Hoffman-la-roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffman-la-roche
Figure Sales and Growth Rate Analysis of Hoffman-la-roche
Figure Revenue and Market Share Analysis of Hoffman-la-roche
Table Product and Service Introduction of Hoffman-la-roche
Table Company Profile and Development Status of Sandoz
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
Figure Sales and Growth Rate Analysis of Sandoz
Figure Revenue and Market Share Analysis of Sandoz
Table Product and Service Introduction of Sandoz
Table Company Profile and Development Status of Rare disease therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rare disease therapeutics
Figure Sales and Growth Rate Analysis of Rare disease therapeutics
Figure Revenue and Market Share Analysis of Rare disease therapeutics
Table Product and Service Introduction of Rare disease therapeutics
Table Company Profile and Development Status of Boehringer ingelheim
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer ingelheim
Figure Sales and Growth Rate Analysis of Boehringer ingelheim
Figure Revenue and Market Share Analysis of Boehringer ingelheim
Table Product and Service Introduction of Boehringer ingelheim
Table Company Profile and Development Status of Hospira
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
Figure Sales and Growth Rate Analysis of Hospira
Figure Revenue and Market Share Analysis of Hospira
Table Product and Service Introduction of Hospira
Table Company Profile and Development Status of Revo biologics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Revo biologics
Figure Sales and Growth Rate Analysis of Revo biologics
Figure Revenue and Market Share Analysis of Revo biologics
Table Product and Service Introduction of Revo biologics
Table Company Profile and Development Status of Eisai
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
Figure Sales and Growth Rate Analysis of Eisai
Figure Revenue and Market Share Analysis of Eisai
Table Product and Service Introduction of Eisai
Table Company Profile and Development Status of Merck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
Figure Sales and Growth Rate Analysis of Merck
Figure Revenue and Market Share Analysis of Merck
Table Product and Service Introduction of Merck
Table Company Profile and Development Status of Glaxosmithkline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxosmithkline
Figure Sales and Growth Rate Analysis of Glaxosmithkline
Figure Revenue and Market Share Analysis of Glaxosmithkline
Table Product and Service Introduction of Glaxosmithkline
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of Octapharma pharmazeutika produktionsges.m.b.h
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma pharmazeutika produktionsges.m.b.h
Figure Sales and Growth Rate Analysis of Octapharma pharmazeutika produktionsges.m.b.h
Figure Revenue and Market Share Analysis of Octapharma pharmazeutika produktionsges.m.b.h
Table Product and Service Introduction of Octapharma pharmazeutika produktionsges.m.b.h
Table Company Profile and Development Status of Omrix biopharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omrix biopharmaceuticals
Figure Sales and Growth Rate Analysis of Omrix biopharmaceuticals
Figure Revenue and Market Share Analysis of Omrix biopharmaceuticals
Table Product and Service Introduction of Omrix biopharmaceuticals
Table Company Profile and Development Status of Affymax
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affymax
Figure Sales and Growth Rate Analysis of Affymax
Figure Revenue and Market Share Analysis of Affymax
Table Product and Service Introduction of Affymax
Table Company Profile and Development Status of Biogen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
Figure Sales and Growth Rate Analysis of Biogen
Figure Revenue and Market Share Analysis of Biogen
Table Product and Service Introduction of Biogen
Table Company Profile and Development Status of Biotest pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest pharmaceuticals
Figure Sales and Growth Rate Analysis of Biotest pharmaceuticals
Figure Revenue and Market Share Analysis of Biotest pharmaceuticals
Table Product and Service Introduction of Biotest pharmaceuticals
Table Company Profile and Development Status of Johnson & johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & johnson
Figure Sales and Growth Rate Analysis of Johnson & johnson
Figure Revenue and Market Share Analysis of Johnson & johnson
Table Product and Service Introduction of Johnson & johnson
Table Company Profile and Development Status of Csl
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Csl
Figure Sales and Growth Rate Analysis of Csl
Figure Revenue and Market Share Analysis of Csl
Table Product and Service Introduction of Csl
Table Company Profile and Development Status of Allergan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
Figure Sales and Growth Rate Analysis of Allergan
Figure Revenue and Market Share Analysis of Allergan
Table Product and Service Introduction of Allergan
Table Company Profile and Development Status of Sanofi
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
Figure Sales and Growth Rate Analysis of Sanofi
Figure Revenue and Market Share Analysis of Sanofi
Table Product and Service Introduction of Sanofi
Table Company Profile and Development Status of Lundbeck
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck
Figure Sales and Growth Rate Analysis of Lundbeck
Figure Revenue and Market Share Analysis of Lundbeck
Table Product and Service Introduction of Lundbeck
Table Company Profile and Development Status of Medimmune
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune
Figure Sales and Growth Rate Analysis of Medimmune
Figure Revenue and Market Share Analysis of Medimmune
Table Product and Service Introduction of Medimmune
Table Company Profile and Development Status of Grifols biologicals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols biologicals
Figure Sales and Growth Rate Analysis of Grifols biologicals
Figure Revenue and Market Share Analysis of Grifols biologicals
Table Product and Service Introduction of Grifols biologicals
-
